Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE)

BACKGROUND: Subcutaneous immunotherapy with high dose grass pollen (typically microgram quantities) was first described over 100 years ago. This treatment suppresses allergen-induced cutaneous late responses, with lesser effects on early responses. We previously reported that repeated 2-weekly intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Slovick, Anna, Douiri, Abdel, Kelly, Joanna, Guerra, Andrea, Muir, Rachel, Tsioulos, Konstantinos, Murphy, Caroline, Shamji, Mohamed H, Ying, Sun, Durham, Stephen R, Till, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765857/
https://www.ncbi.nlm.nih.gov/pubmed/23965180
http://dx.doi.org/10.1186/2045-7022-3-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765857/
https://www.ncbi.nlm.nih.gov/pubmed/23965180
http://dx.doi.org/10.1186/2045-7022-3-27

Ejemplares similares